The GEO Group (GEO) Q2 2026 earnings review

Federal Activations Power a Beat and Raise, But State Delays Hide in the Details

GEO Group reported a highly successful Q2 2026, realizing the financial fruits of its aggressive 2025 contract winning streak. Revenue climbed 15% year-over-year to $732.1 million, while Adjusted EBITDA surged 20% to $142.0 million, demonstrating strong operational leverage driven by lower labor costs. Management raised full-year guidance across all key metrics and announced two new federal contracts (Big Horn and Rivers) that will secure 2027 revenue. However, a major red flag was quietly disclosed: the highly anticipated $100 million Florida DOC managed-only contracts have been delayed by a full year to July 2027.

🐂 Bull Case

Federal Pipeline is Delivering

The massive 2025 contract wins are now officially generating cash. Furthermore, the new Big Horn and Rivers contracts add another $165M in annualized revenue starting early 2027, with ICE reimbursing all activation CapEx.

Deleveraging Milestone Reached

Net leverage has dropped below 3.0x Adjusted EBITDA, a critical financial target that derisks the balance sheet and clears the runway for sustained share repurchases.

🐻 Bear Case

Florida DOC Contract Delayed

The $100M Graceville and Bay facility transitions were suddenly pushed from July 2026 to July 2027. This rips a chunk of expected growth out of late-2026 models.

Labor Tailwinds Moderating

A significant portion of Q2's EBITDA beat was driven by 'lower labor costs.' Management explicitly warned that guidance assumes a more moderate contribution from these savings in the second half.

⚖️ Verdict: 🟢

Bullish. The core thesis—scaling federal detention capacity alongside ICE—is fully materializing in the P&L. The delayed Florida contracts are a frustrating headwind, but the federal momentum and deleveraged balance sheet are more than enough to drive the stock forward.

Key Themes

DRIVER NEW 🟢🟢

ICE Facility Activations Secure 2027 Growth

GEO continues to successfully monetize its idle infrastructure. In Q2, it announced two new 5-year support services contracts with ICE for the 1,188-bed Big Horn Facility ($85M/year) and the 1,320-bed Rivers Facility ($80M/year). Crucially, ICE is reimbursing the capital expenditures needed to reactivate these sites. Operations and earnings from both will normalize in early 2027, locking in a predictable growth runway.

CONCERN NEW 🔴

Florida State Contracts Delayed (Contradicting Growth Narrative)

While the federal narrative is flawless, the state-level execution stumbled. In previous quarters, management touted the 1,884-bed Graceville and 985-bed Bay Florida DOC contracts as generating $100 million in combined annualized revenue starting July 1, 2026. The Q2 release quietly notes this transition is now delayed to July 1, 2027. This pushes a highly anticipated margin and revenue driver out by a full 12 months.

CONCERN NEW 🔴

The Ghost of ICE Facility Sales

During the Q1 2026 call, CEO George Zoley heavily promoted the potential sale of multiple GEO facilities directly to ICE, calling it a 'significant liquidity and shareholder value-enhancing event' that could happen as early as Q2 or Q3. The Q2 earnings release contains zero mention of these sales. Investors should question if this highly anticipated catalyst is dead or just delayed.

DRIVER 🟢

Capital Return Strategy Delivering

With net leverage now firmly below 3.0x, GEO is consistently executing its $500M buyback authorization. The company repurchased 1.6 million shares for $36.6M in Q2. Life-to-date, they have bought back 10.1 million shares for $177M, aggressively shrinking the float while debt levels remain manageable.

DRIVER 🟢

ISAP Technology Shift Driving Value

Though not explicitly updated in the Q2 release, prior quarters established that GEO's Intensive Supervision Appearance Program (ISAP) is experiencing a highly favorable technology mix shift. The transition of participants from lower-margin SmartLINK apps to higher-priced BI Incorporated GPS ankle monitors acts as an invisible margin driver supporting the broader EBITDA acceleration.

CONCERN

Macro: Total Dependency on Federal Immigration Policy

GEO is functionally a massive derivative of U.S. federal immigration policy. The company relies entirely on continued ICE funding allocations and aggressive detention postures to fill its activated capacity. As political administrations shift, the risk of sudden policy reversals regarding the 100,000-bed national detention target remains the ultimate structural vulnerability.

CONCERN NEW 🔴

Moderating Labor Tailwinds

Management attributed a portion of the Q2 Adjusted EBITDA beat to 'lower labor costs.' However, they explicitly noted that the second-half 2026 guidance assumes a 'more moderate contribution' from these savings. If labor inflation returns or hiring ramps up heavily for the new ICE facilities, margin expansion could stall in Q3 and Q4.

Other KPIs

Net Leverage Below 3.0x

Total net debt sits at approximately $1.5 billion. Achieving a net leverage ratio below 3.0x Adjusted EBITDA is a massive de-risking event compared to historical levels, giving GEO total flexibility to balance CapEx, debt repayment, and share repurchases.

Unreimbursed Capital Expenditures (FY26) $135M - $145M

Despite activating new facilities, GEO's unreimbursed CapEx remains controlled, largely because ICE is funding the reactivation capital for the Big Horn and Rivers facilities. This protects free cash flow for continued stock buybacks.

Guidance

FY26 Revenue $2.95B - $3.05B

Stable. This guidance range maintains a massive baseline of revenue generated from the 2025 pipeline activations, representing roughly ~17% YoY growth at the midpoint compared to FY25's $2.56B run rate.

FY26 Adjusted EBITDA $550M - $560M

Accelerating. Raised from prior expectations. This reflects the realization of operating leverage across the expanded federal detention footprint, supported by temporary Q2 labor cost efficiencies.

Q3 2026 Revenue $755M - $805M

Accelerating. Implies sequential growth from Q2's $732.1M and significant YoY growth as the activated facilities continue their occupancy ramp-ups.

Q3 2026 Adjusted EBITDA $140M - $145M

Stable. Essentially flat to Q2's $142.0M, reflecting management's caution that the labor cost benefits experienced in Q2 will begin to moderate.

Key Questions

Florida DOC Contract Delay

What specific operational, staffing, or bureaucratic hurdles caused the transition of the Graceville and Bay managed-only contracts to be pushed out an entire year to July 2027?

Status of ICE Facility Sales

Last quarter, you highlighted active discussions regarding the potential sale of multiple GEO facilities directly to ICE. Has that initiative stalled, or is it simply taking longer than expected to navigate federal procurement processes?

Labor Cost Mechanics

You cited lower labor costs as a tailwind in Q2 but expect it to moderate. Is this moderation due to necessary hiring to meet minimum staffing levels at ramping facilities, or are you forecasting general wage inflation in H2?

Big Horn and Rivers Activation Risks

With the Big Horn and Rivers facilities coming online in late 2026, are you experiencing any bottlenecks in recruiting or federal clearance times that could delay their early 2027 earnings contribution?